Intranasal immunization with a rNMB0315 and combination adjuvants induces protective immunity against Neisseria meningitidis serogroup B in mice
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intranasal immunization with a rNMB0315 and combination adjuvants induces protective immunity against Neisseria meningitidis serogroup B in mice
Authors
Keywords
Neisseria meningitidis, serogroup B, NMB0315, Moucosal vaccine, Chitosan nanoparticle, Immunopotentiators
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 93, Issue -, Pages 107411
Publisher
Elsevier BV
Online
2021-02-06
DOI
10.1016/j.intimp.2021.107411
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia
- (2020) Helen S. Marshall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Understanding immunogenicity assessments for meningococcal serogroup B vaccines
- (2020) Paul Balmer et al. POSTGRADUATE MEDICINE
- Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains
- (2020) Kathryn A. Matthias et al. VACCINE
- Location, Location, Location—Commensalism, Damage and Evolution of the Pathogenic Neisseria
- (2019) H Steven Seifert JOURNAL OF MOLECULAR BIOLOGY
- Immunogenicity and protective efficacy of mucosal delivery of recombinant hcp of Campylobacter jejuni Type VI secretion system (T6SS) in chickens
- (2019) Ankita Singh et al. MOLECULAR IMMUNOLOGY
- The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
- (2019) Vega Masignani et al. Frontiers in Immunology
- Chimeric hepatitis B virus core particles displaying Neisserial surface protein A confer protection against virulent Neisseria meningitidis serogroup B in BALB/c mice
- (2019) YongLi Hou et al. International Journal of Nanomedicine
- Mucosal Immune Response in Nasal-Associated Lymphoid Tissue upon Intranasal Administration by Adjuvants
- (2018) Hiromi Takaki et al. Journal of Innate Immunity
- Nasal nanovaccines
- (2017) B. Bernocchi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Improved sustained release of antigen from immunostimulatory DNA hydrogel by electrostatic interaction with chitosan
- (2017) Yumiko Ishii-Mizuno et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nanodelivery systems for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides
- (2017) Huijie Zhang et al. Materials Science & Engineering C-Materials for Biological Applications
- Adjuvant Activity of Poly-ε-caprolactone/Chitosan Nanoparticles Characterized by Mast Cell Activation and IFN-γ and IL-17 Production
- (2017) Sandra Jesus et al. MOLECULAR PHARMACEUTICS
- Biological Functions of the Secretome of Neisseria meningitidis
- (2017) Jan Tommassen et al. Frontiers in Cellular and Infection Microbiology
- Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59
- (2017) Shu-Ting Ren et al. PLoS One
- PLGA nano/micro particles encapsulated with pertussis toxoid (PTd) enhances Th1/Th17 immune response in a murine model
- (2016) Pan Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery
- (2016) Nirmal Marasini et al. Nanomedicine
- Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles
- (2015) Atul Srivastava et al. APMIS
- Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity
- (2015) D. Bento et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine
- (2015) Duccio Medini et al. VACCINE
- A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice
- (2015) Rolando Pajon et al. VACCINE
- Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice
- (2015) Lingbin Zeng et al. VACCINE
- Advances and challenges in mucosal adjuvant technology
- (2015) Daniel Newsted et al. VACCINE
- Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies
- (2015) Shujing Wang et al. Protein & Cell
- Mucosal Immunity and B Cells in Teleosts: Effect of Vaccination and Stress
- (2015) David Parra et al. Frontiers in Immunology
- Validation of a New 96-Well Plate Spectrophotometric Method for the Quantification of Compound 48/80 Associated with Particles
- (2013) Dulce Bento et al. AAPS PHARMSCITECH
- Specific Serum Ig Recognizing Staphylococcal Wall Teichoic Acid Induces Complement-Mediated Opsonophagocytosis against Staphylococcus aureus
- (2012) D.-J. Jung et al. JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started